Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX in Postherpetic Neuralgia
NCT00168441Phase 2Completed
- Sponsor
- Allergan
- Start
- Jun 2004
- Primary completion
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of onabotulinumtoxinA in postherpetic neuralgia (PHN), sponsored by Allergan. Started Jun 2004; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00168441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168441.